Delivery Order SPE2DB20D1004-SPE2DB25FNKMZ
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,033.03 by the Defense Logistics Agency on August 26, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injections, with a contract ceiling value of $2,720.90 and a completion date of June 26, 2025. This competitive, non-set-aside delivery order utilizes firm fixed pricing and represents a single pharmaceutical supply transaction under AmerisourceBergen's existing federal contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which is also the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,722.19 to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pen injections on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $2,955.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for supply of Mounjaro 7.5 mg/0.5 mL pens on July 15, 2025, with completion targeted for July 16, 2025. This non-set-aside delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors with a completion date of August 19, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical...
- The Defense Logistics Agency awarded a $2,360.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on July 25, 2025, with a completion date of July 28, 2025. This non-competitive delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the Department of Defense medical supply chain. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,850.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on September 26, 2025, with completion expected by September 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a child contract under this prime vehicle, the delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.81 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pen injections. This competitive, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,073.50 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injections (0.5 mL units). This is a firm fixed price delivery order with an ultimate completion date of September 15, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,123.03 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order, issued without a set-aside designation, represents a competitively awarded pharmaceutical supply transaction supporting federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNKMZDelivery Order
The Defense Logistics Agency awarded a $2,924.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 2.5 mg/0.5 ml pen injections with an ultimate completion date of September 5, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999.99 billion ceiling value through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, supplying medications and medical supplies to military and veteran healthcare systems. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply arrangement with the Defense Logistics Agency, which enables the company to distribute a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs globally. The award demonstrates the company's ongoing role as a prime vendor in the federal medical supply chain, fulfilling discrete product requests through individual delivery orders issued against the master IDC. Performance will be executed from the company's Conshohocken facility, which serves as the corporate office and primary distribution hub for federal pharmaceutical contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/4/25 |